Neoleukin Therapeutics Plans 1-For-5 Reverse Stock Split
Portfolio Pulse from Benzinga Newsdesk
Neoleukin Therapeutics has announced a 1-for-5 reverse stock split, which will become effective at 12:01 a.m. Eastern time on September 25, 2023.
September 22, 2023 | 12:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Neoleukin Therapeutics' 1-for-5 reverse stock split may lead to a temporary increase in stock price due to reduced supply.
Reverse stock splits reduce the number of shares available in the market, which can lead to a temporary increase in the stock price due to reduced supply. However, the long-term impact depends on the company's fundamentals and market sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100